,i #aad? ,,congress #a/ ,session ,h4 ,r4 #bfbi ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,june #c1 #bjae ,mr4 ,%imkus 7= himself & ,mr4 ,g5e ,gre5 ( ,texas7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to am5d ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act ) respect to ! approval ( c]ta9 antibact]ial & antifungal drugs1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,antibiotic ,developm5t to ,advance ,pati5t ,treatm5t ,act4 #b4 ,approval ( c]ta9 drugs = use 9 a limit$ population ( pati5ts 7a7 ,purpose ,! purpose ( ?is section is to help exp$ite ! developm5t & availability ( treatm5ts = s]i\s or life-?reat5+ bact]ial or fungal infections 9 pati5ts ) unmet ne$s1 :ile ma9ta9+ safety & effectiv5ess /&>ds = su* treatm5ts1 tak+ into acc\nt ! sev]ity ( ! infection & ! availability or lack ( alt]native treatm5ts4 7b7 ,approval ( c]ta9 antibact]ial & antifungal drugs ,section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 is am5d$ by add+ at ! end ! foll[+ new subsection3 7x7 ,approval ( c]ta9 antibact]ial & antifungal drugs = use 9 a limit$ population ( pati5ts 7#a7 ,process ,at ! reque/ ( ! sponsor ( an antibact]ial or antifungal drug t is int5d$ to treat a s]i\s or life-?reat5+ infection1 ! ,secret>y-- 7,a7 may execute a writt5 agreem5t ) ! sponsor on ! process = develop+ data to support an application = approval ( su* drug1 = use 9 a limit$ population ( pati5ts 9 accordance ) ?is subsection2 7,b7 %all proce$ 9 accordance ) ?is subsection only if a writt5 agreem5t is rea*$ "u subp>agraph 7,a72 7,c7 %all provide ! sponsor ) an opportunity to reque/ meet+s "u p>agraph 7#b72 7,d7 if a writt5 agreem5t is rea*$ "u subp>agraph 7,a71 may approve ! drug "u ?is subsection = su* use-- 7i7 9 a limit$ population ( pati5ts = :i* !re is an unmet m$ical ne$2 7ii7 bas$ on a /reaml9$ developm5t program2 & 7iii7 only if ! /&>ds = approval "u subsections 7c7 & 7d7 ( ?is section or lic5sure "u section #cea ( ! ,public ,heal? ,s]vice ,act1 z applicable1 are met2 & 7,e7 9 approv+ a drug 9 accordance ) ?is subsection1 subject to subp>agraph 7,d77iii71 may rely ^u-- 7i7 traditional endpo9ts1 alt]nate endpo9ts1 or a comb9ation ( traditional & alt]nate endpo9ts1 &1 z appropriate1 data sets ( a limit$ size2 & 7ii7 7,i7 additional data1 includ+ precl9ical1 ph>macologic1 or pa?ophysiologic evid5ce2 7,,ii7 noncl9ical susceptibility & ph>macok9etic data2 7,,iii7 data f phase #b cl9ical trials2 & 7,,iv7 su* o!r confirmatory evid5ce z ! ,secret>y det]m9es appropriate to approve ! drug4 7#b7 ,=mal meet+s 7,a7 ,9 g5]al ,to help exp$ite & facilitate ! developm5t & review ( a drug = :i* a sponsor int5ds to reque/ approval 9 accordance ) ?is subsection1 ! ,secret>y may1 at ! reque/ ( ! sponsor1 conduct meet+s t provide e>ly consultation1 timely advice1 & suffici5t opportunities to develop an agreem5t describ$ 9 p>agraph 7#a77;,a7 & help ! sponsor design & conduct a drug developm5t program z effici5tly z possible1 includ+ ! foll[+ types ( meet+s3 7i7 ,an e>ly consultation meet+4 7ii7 ,an assessm5t meet+4 7iii7 ,a po/approval meet+4 7,b7 ,no alt]+ ( goals ,no?+ 9 ?is p>agraph %all be con/ru$ to alt] agre$ ^u goals & proc$ures id5tifi$ 9 ! lett]s describ$ 9 section #aja7;b7 ( ! ,prescription ,drug ,us] ,fee ,am5dm5ts ( #bjab4 7,c7 ,break?r\gh !rapies ,9 ! case ( a drug designat$ z a break?r\gh !rapy "u section #ejf7;a71 ! sponsor ( su* drug may elect to utilize meet+s provid$ "u su* section ) respect to su* drug 9 lieu ( meet+s describ$ 9 subp>agraph 7,a74 7#c7 ,label+ requirem5t ,! label+ ( an antibact]ial or antifungal drug approv$ 9 accordance ) ?is subsection %all conta9 ! /atem5t ,limit$ ,population 9 a prom95t mann] & adjac5t to1 & n m prom95t ?an1 ! br& "n ( ! product4 ,! prescrib+ in=mation = su* antibact]ial or antifungal drug requir$ by section #bja4eg ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulation7 %all also include ! foll[+ /atem5t3 ,?is drug is indicat$ = use 9 a limit$ & specific population ( pati5ts44 7#d7 ,promotional mat]ials ,! provisions ( section #ejf7;c77#b77;,b7 %all apply ) respect to approval 9 accordance ) ?is subsection to ! same ext5t & 9 ! same mann] z su* provisions apply ) respect to accel]at$ approval 9 accordance ) section #ejf7;c77#a74 7#e7 ,t]m9ation ( requirem5ts or conditions ,if a drug is approv$ 9 accordance ) ?is subsection = an indication 9 a limit$ population ( pati5ts & is subsequ5tly approv$ or lic5s$ "u ?is section or section #cea ( ! ,public ,heal? ,s]vice ,act1 o!r ?an 9 accordance ) ?is subsection1 =-- 7,a7 ! same indication & ! same conditions ( use1 ! ,secret>y %all remove any label+ requirem5ts or po/m>ket+ conditions t 7 made applicable to ! drug "u ?is subsection2 or 7,b7 a diff]5t indication or condition ( use1 ! ,secret>y %all n apply ! label+ requirem5ts & po/m>ket+ conditions t 7 made applicable to ! drug "u ?is subsection to ! subsequ5t approval ( ! drug = su* diff]5t indication or condition ( use4 7#f7 ,relation to o!r provisions ,no?+ 9 ?is subsection %all be con/ru$ to prohibit ! approval ( a drug = use 9 a limit$ population ( pati5ts 9 accordance ) ?is subsection1 9 comb9ation )-- 7,a7 an agreem5t on ! design & size ( a cl9ical trial pursuant to subp>agraphs 7,b7 & 7,c7 ( subsection 7b77#e72 7,b7 designation & treatm5t ( ! drug z a break?r\gh !rapy "u section #ejf7;a72 7,c7 designation & treatm5t ( ! drug z a fa/ track product "u section #ejf7;b72 or 7,d7 accel]at$ approval ( ! drug 9 accordance ) section #ejf7;c74 7#g7 ,rule ( con/ruction ,no?+ 9 ?is subsection %all be con/ru$-- 7,a7 to alt] ! /&>ds ( evid5ce "u subsection 7c7 or 7d7 7includ+ ! sub/antial evid5ce /&>d 9 subsection 7d772 7,b7 to waive or o!rwise preclude ! application ( requirem5ts "u subsection 7o72 7,c7 to o!rwise1 9 any way1 limit ! au?ority ( ! ,secret>y to approve products pursuant to ?is ,act & ! ,public ,heal? ,s]vice ,act z au?oriz$ prior to ! date ( enactm5t ( ?is subsection2 or 7,d7 to re/rict 9 any mann]1 ! prescrib+ ( antibiotics or o!r products by heal? c>e provid]s1 or to o!rwise limit or re/rict ! practice ( heal? c>e4 7#h7 ,effective imm$iately ,! ,secret>y %all h ! au?orities ve/$ 9 ! ,secret>y by ?is subsection beg9n+ on ! date ( enactm5t ( ?is subsection1 irrespective ( :5 & :e!r ! ,secret>y promulgates f9al regulations or guidance4 7#i7 ,def9itions ,9 ?is subsection3 7,a7 ,e>ly consultation meet+ ,! t]m e>ly consultation meet+ means a pre-inve/igational new drug meet+ or an end-(-phase #a meet+ t-- 7i7 is conduct$ to review & rea* a writt5 agreem5t-- 7,i7 on ! scope ( ! /reaml9$ developm5t plan = a drug = :i* a sponsor int5ds to reque/ approval 9 accordance ) ?is subsection2 & 7,,ii7 :i*1 z appropriate1 may include agreem5t on ! design & size ( necess>y precl9ical & cl9ical /udies e>ly 9 ! developm5t process1 includ+ cl9ical trials ^: data are int5d$ to =m ! prim>y basis = an effectiv5ess claim2 & 7ii7 provides an opportunity to discuss expectations ( ! ,secret>y reg>d+ /udies or o!r in=mation t ! ,secret>y deems appropriate = purposes ( apply+ p>agraph 7#e71 relat+ to ! t]m9ation ( label+ requirem5ts or po/m>ket+ conditions4 7,b7 ,assessm5t meet+ ,! t]m assessm5t meet+ means an end-(-phase #b meet+1 pre-new drug application meet+1 or pre-biologics lic5se application meet+ conduct$ to resolve que/ions & issues rais$ dur+ ! c\rse ( cl9ical inve/igations1 & details address$ 9 ! writt5 agreem5t reg>d+ po/approval commitm5ts or expansion ( approv$ uses4 7,c7 ,po/approval meet+ ,! t]m po/approval meet+ means a meet+ foll[+ initial approval or lic5sure ( ! drug = use 9 a limit$ population1 to discuss any issues id5tifi$ by ! ,secret>y or ! sponsor reg>d+ po/approval commitm5ts or expansion ( approv$ uses4 4 7c7 ,guidance ,n lat] ?an #ah mon?s aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices1 act+ ?r\gh ! ,commission] ( ,food & ,drugs1 %all issue draft guidance describ+ crit]ia1 process1 & o!r g5]al consid]ations = demon/rat+ ! safety & effectiv5ess ( antibact]ial & antifungal drugs to be approv$ = use 9 a limit$ population 9 accordance ) section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 z add$ by subsection 7b74 7d7 ,con=m+ am5dm5ts 7#a7 ,lic5sure ( c]ta9 biological products ,section #cea7;j7 ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb7;j77 is am5d$-- 7,a7 by /rik+ 7j7 & ins]t+ 7j77#a72 7,b7 by ins]t+ #eje7x71 aft] #eje7p712 & 7,c7 by add+ at ! end ! foll[+ new p>agraph3 7#b7 ,9 apply+ section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act to ! lic5sure ( biological products "u ?is section-- 7,a7 ref]5ces to an antibact]ial or antifungal drug t is int5d$ to treat a s]i\s or life-?reat5+ infection %all be con/ru$ to ref] to a biological product int5d$ to treat a s]i\s or life-?reat5+ bact]ial or fungal infection2 & 7,b7 ref]5ces to approval ( a drug "u section #eje7;c7 ( su* ,act %all be con/ru$ to ref] to a lic5sure ( a biological product "u subsection 7a7 ( ?is section4 4 7#b7 ,misbr&+ ,section #ejb ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb7 is am5d$ by add+ at ! end ! foll[+ new subsection3 7dd7 ,if x is a drug approv$ 9 accordance ) section #eje7x7 & its label+ does n meet ! requirem5ts "u p>agraph 7#c7 ( su* subsection1 subject to p>agraph 7#e7 ( su* subsection4 4 7e7 ,evaluation 7#a7 ,assessm5t ,n lat] ?an #dh mon?s aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices %all publi% = public comm5t an assessm5t ( ! program e/abli%$ "u section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 z add$ by subsection 7b74 ,su* assessm5t %all det]m9e if ! limit$-use pa?way e/abli%$ "u su* section #eje7x7 has improv$ or is likely to improve pati5t access to novel antibact]ial or antifungal treatm5ts & assess h[ ! pa?way c\ld be exp&$ to cov] products = s]i\s or life-?reat5+ diseases or conditions beyond bact]ial & fungal infections4 7#b7 ,meet+ ,n lat] ?an #ij days aft] ! date ( ! publication ( su* assessm5t1 ! ,secret>y1 act+ ?r\gh ! ,commission] ( ,food & ,drugs %all hold a public meet+ to discuss ! f9d+s ( ! assessm5t1 dur+ :i* public /akehold]s may pres5t _! views on ! success ( ! program e/abli%$ "u section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 z add$ by subsection 7b71 & ! appropriat5ess ( exp&+ su* program4 7f7 ,expansion ( program ,if ! ,secret>y ( ,heal? & ,human ,s]vices det]m9es1 bas$ on ! assessm5t "u subsection 7e77#a71 evaluation ( ! assessm5t1 & any o!r relevant in=mation1 t ! public heal? w\ld b5efit f expansion ( ! limit$-use pa?way e/abli%$ "u section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7z add$ by subsection 7b77 beyond ! drugs approv$ 9 accordance ) su* section1 ! ,secret>y may exp& su* limit$-use pa?way 9 accordance ) su* a det]m9ation4 ,! approval ( any drugs "u any su* expansion %all be subject to ! consid]ations & requirem5ts describ$ 9 su* section #eje7x7 = purposes ( expansion to o!r s]i\s or life-?reat5+ diseases or conditions4 7g7 ,monitor+ ,! ,public ,heal? ,s]vice ,act is am5d$ by ins]t+ aft] section #cag,t 7#db ,u4,s4,c4 #bdg;b-#bb7 ! foll[+3 #cag,u4 ,monitor+ antibact]ial & antifungal drug use & resi/ance 7a7 ,monitor+ ,! ,secret>y %all use an appropriate monitor+ sy/em to monitor-- 7#a7 ! use ( antibact]ial & antifungal drugs1 includ+ ^? receiv+ approval or lic5sure = a limit$ population pursuant to section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act2 & 7#b7 *anges 9 bact]ial & fungal resi/ance to drugs4 7b7 ,public availability ( data ,! ,secret>y %all make summ>ies ( ! data d]iv$ f monitor+ "u ?is section publicly available = ! purposes (-- 7#a7 improv+ ! monitor+ ( important tr5ds 9 antibact]ial & antifungal resi/ance2 & 7#b7 ensur+ appropriate /ew>d%ip ( antibact]ial & antifungal drugs1 includ+ ^? receiv+ approval or lic5sure = a limit$ population pursuant to section #eje7x7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act4 4 #c4 ,susceptibility te/ int]pretive crit]ia = microorganisms 7a7 ,9 g5]al ,section #eaa ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;a7 is am5d$ to read z foll[s3 #eaa4 ,id5tify+ & updat+ susceptibility te/ int]pretive crit]ia = microorganisms 7a7 ,purpose2 ,id5tification ( crit]ia 7#a7 ,purpose ,! purpose ( ?is section is to provide ! ,secret>y ) an exp$it$1 flexible me?od =-- 7,a7 cle>ance or prem>ket approval ( antimicrobial susceptibility te/+ devices utiliz+ updat$1 recogniz$ susceptibility te/ int]pretive crit]ia to *>act]ize ! 9 vitro susceptibility ( p>ticul> bact]ia1 fungi1 or o!r microorganisms to antimicrobial drugs2 & 7,b7 provid+ public notice ( ! availability ( recogniz$ int]pretive crit]ia to meet prem>ket submission requirem5ts or o!r requirem5ts "u ?is ,act = antimicrobial susceptibility te/+ devices4 7#b7 ,9 g5]al ,! ,secret>y %all id5tify appropriate susceptibility te/ int]pretive crit]ia ) respect to antimicrobial drugs-- 7,a7 if su* crit]ia are available on ! date ( approval ( ! drug "u section #eje ( ?is ,act or lic5sure ( ! drug "u section #cea ( ! ,public ,heal? ,s]vice ,act 7z applicable71 ^u su* approval or lic5sure2 or 7,b7 if su* crit]ia are unavailable on su* date1 on ! date on :i* su* crit]ia are available = su* drug4 7#c7 ,bases = initial id5tification ,! ,secret>y %all id5tify appropriate susceptibility te/ int]pretive crit]ia "u p>agraph 7#b71 bas$ on ! ,secret>y's review (1 to ! ext5t available & relevant-- 7,a7 precl9ical & cl9ical data1 includ+ ph>macok9etic1 ph>macodynamic1 & epidemiological data2 7,b7 ,bayesian & ph>macometric /ati/ical me?odologies2 & 7,c7 su* o!r evid5ce & in=mation z ! ,secret>y consid]s appropriate4 7b7 ,susceptibility te/ ,int]pretive ,crit]ia ,website 7#a7 ,9 g5]al ,n lat] ?an #a ye> aft] ! date ( ! enactm5t ( ! ,antibiotic ,developm5t to ,advance ,pati5t ,treatm5t ,act1 ! ,secret>y %all e/abli%1 & ma9ta9 !reaft]1 on ! website ( ! ,food & ,drug ,adm9i/ration1 a d$icat$ website t conta9s a li/ ( any appropriate new or updat$ susceptibility te/ int]pretive crit]ia /&>ds 9 accordance ) p>agraph 7#b7 7ref]r$ to 9 ?is section z ! ,int]pretive ,crit]ia ,website74 7#b7 ,li/+ ( susceptibility te/ int]pretive crit]ia /&>ds 7,a7 ,9 g5]al ,! li/ describ$ 9 p>agraph 7#a7 %all consi/ ( any new or updat$ susceptibility te/ int]pretive crit]ia /&>ds t are-- 7i7 e/abli%$ by a nationally or int]nationally recogniz$ /&>d developm5t organization t-- 7,i7 e/abli%es & ma9ta9s proc$ures to address pot5tial conflicts ( int]e/ & ensure transp>5t decisionmak+2 7,,ii7 holds op5 meet+s to ensure t !re is an opportunity = public input by int]e/$ p>ties1 & e/abli%es & ma9ta9s processes to ensure t su* input is consid]$ 9 decisionmak+2 & 7,,iii7 p]mits its /&>ds to be made publicly available1 ?r\gh ! ,national ,libr>y ( ,m$ic9e or ano!r simil> s\rce acceptable to ! ,secret>y2 & 7ii7 recogniz$ 9 :ole1 or 9 "p1 by ! ,secret>y "u subsection 7c74 7,b7 ,o!r li/ ,! ,int]pretive ,crit]ia ,website %all1 9 addition to ! li/ describ$ 9 subp>agraph 7,a71 include a li/ ( int]pretive crit]ia1 if any1 t ! ,secret>y has det]m9$ to be appropriate ) respect to legally m>ket$ antimicrobial drugs1 :]e-- 7i7 ! ,secret>y does n recognize1 9 :ole or 9 "p1 an int]pretive crit]ia /&>d describ$ "u subp>agraph 7,a7 o!rwise applicable to su* a drug2 7ii7 ! ,secret>y )draws "u subsection 7c77#a77;,b7 recognition ( a /&>d1 9 :ole or 9 "p1 o!rwise applicable to su* a drug2 7iii7 ! ,secret>y approves an application "u section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act1 z applicable1 ) respect to m>ket+ ( su* a drug = :i* !re are no relevant int]pretive crit]ia includ$ 9 a /&>d recogniz$ by ! ,secret>y "u subsection 7c72 or 7iv7 because ! *>act]i/ics ( su* a drug diff] f o!r drugs ) ! same active +r$i5t1 ! int]pretive crit]ia ) respect to su* drug-- 7,i7 diff] f o!rwise applicable int]pretive crit]ia includ$ 9 a /&>d li/$ "u subp>agraph 7,a7 or int]pretive crit]ia o!rwise li/$ "u ?is subp>agraph2 & 7,,ii7 are det]m9$ by ! ,secret>y to be appropriate = ! drug4 7,c7 ,requir$ /atem5ts ( limitations ( in=mation ,! ,int]pretive ,crit]ia ,website %all include ! foll[+3 7i7 ,a /atem5t t-- 7,i7 ! website provides in=mation ab\t ! susceptibility ( bact]ia1 fungi1 or o!r microorganisms to a c]ta9 drug 7or drugs72 & 7,,ii7 ! safety & efficacy ( ! drug 9 treat+ cl9ical infections due to su* bact]ia1 fungi1 or o!r microorganisms may n h be5 e/abli%$ 9 adequate & well-controll$ cl9ical trials & ! cl9ical significance ( su* susceptibility in=mation 9 su* trials is unkn[n4 7ii7 ,a /atem5t t directs heal? c>e practition]s to consult ! approv$ product label+ = specific drugs to det]m9e ! uses = :i* ! ,food & ,drug ,adm9i/ration has approv$ ! product4 7iii7 ,any o!r /atem5t t ! ,secret>y det]m9es appropriate to adequately convey ! limitations ( ! data support+ susceptibility te/ int]pretive crit]ia /&>d li/$ on ! website4 7#c7 ,notice ,n lat] ?an ! date on :i* ! ,int]pretive ,crit]ia ,website is e/abli%$1 ! ,secret>y %all publi% a notice ( t e/abli%m5t 9 ! ,f$]al ,regi/]4 7#d7 ,inapplicability ( misbr&+ provision ,! inclusion 9 ! approv$ label+ ( an antimicrobial drug ( a ref]5ce or hyp]l9k to ! ,int]pretive ,crit]ia ,website1 9 & ( itself1 %all n cause ! drug to be misbr&$ 9 violation ( section #ejb1 or ! regulations promulgat$ !reund]4 7#e7 ,trade secrets & confid5tial in=mation ,no?+ 9 ?is section %all be con/ru$ z au?oriz+ ! ,secret>y to disclose any in=mation t is a trade secret or confid5tial in=mation subject to section #eeb7;b77#d7 ( title #e1 ,unit$ ,/ates ,code4 7c7 ,recognition ( susceptibility te/ int]pretive crit]ia f /&>d developm5t organizations 7#a7 ,9 g5]al ,beg9n+ on ! date ( ! e/abli%m5t ( ! ,int]pretive ,crit]ia ,website1 & at lea/ e #f mon?s !reaft]1 ! ,secret>y %all-- 7,a7 evaluate any appropriate new or updat$ susceptibility te/ int]pretive crit]ia /&>ds e/abli%$ by a nationally or int]nationally recogniz$ /&>d developm5t organization describ$ 9 subsection 7b77#b77;,a77i72 & 7,b7 publi% on ! public website ( ! ,food & ,drug ,adm9i/ration a notice-- 7i7 )draw+ recognition ( any diff]5t susceptibility te/ int]pretive crit]ia /&>d1 9 :ole or 9 "p2 7ii7 recogniz+ ! new or updat$ /&>ds2 7iii7 recogniz+ "o or m p>ts ( ! new or updat$ int]pretive crit]ia specifi$ 9 su* a /&>d & decl9+ to recognize ! rema9d] ( su* /&>d2 & 7iv7 mak+ any necess>y updates to ! li/s "u subsection 7b77#b74 7#b7 ,bases = updat+ int]pretive crit]ia /&>ds ,9 evaluat+ new or updat$ susceptibility te/ int]pretive crit]ia /&>ds "u p>agraph 7#a77;,a71 ! ,secret>y may consid]-- 7,a7 ! ,secret>y's det]m9ation t su* a /&>d is n applicable to a p>ticul> drug because ! *>act]i/ics ( ! drug diff] f o!r drugs ) ! same active +r$i5t2 7,b7 in=mation provid$ by int]e/$ ?ird p>ties1 includ+ public comm5t on ! annual compilation ( notices publi%$ "u p>agraph 7#c72 7,c7 any bases us$ to id5tify susceptibility te/ int]pretive crit]ia "u subsection 7a77#b72 & 7,d7 su* o!r in=mation or factors z ! ,secret>y det]m9es appropriate4 7#c7 ,annual compilation ( notices ,ea* ye>1 ! ,secret>y %all compile ! notices publi%$ "u p>agraph 7#a77;,b7 & publi% su* compilation 9 ! ,f$]al ,regi/] & provide = public comm5t4 ,if ! ,secret>y receives comm5ts1 ! ,secret>y w review su* comm5ts &1 if ! ,secret>y det]m9es appropriate1 update pursuant to ?is subsection susceptibility te/ int]pretive crit]ia /&>ds-- 7,a7 recogniz$ by ! ,secret>y "u ?is subsection2 or 7,b7 o!rwise li/$ on ! ,int]pretive ,crit]ia ,website "u subsection 7b77#b74 7#d7 ,relation to section #ead7;c7 ,any susceptibility te/ int]pretive /&>d recogniz$ "u ?is subsection or any crit]ia o!rwise li/$ "u subsection 7b77#b77;,b7 %all be deem$ to be recogniz$ z a /&>d by ! ,secret>y "u section #ead7;c77#a74 7#e7 ,volunt>y use ( int]pretive crit]ia ,no?+ 9 ?is section prohibits a p]son f seek+ approval or cle>ance ( a drug or device1 or *anges to ! drug or ! device1 on ! basis ( susceptibility te/ int]pretive crit]ia /&>ds :i* diff] f ^? recogniz$ pursuant to p>agraph 7#a74 7d7 ,antimicrobial drug label+ 7#a7 ,drugs m>ket$ prior to e/abli%m5t ( ,int]pretive ,crit]ia ,website ,) respect to an antimicrobial drug lawfully introduc$ or deliv]$ = introduction into int]/ate comm]ce = comm]cial di/ribution be=e ! e/abli%m5t ( ! ,int]pretive ,crit]ia ,website1 a hold] ( an approv$ application "u section #eje or section #cea ( ! ,public ,heal? ,s]vice ,act1 z applicable1 = ea* su* drug-- 7,a7 n lat] ?an #a ye> aft] e/abli%m5t ( ! ,int]pretive ,crit]ia ,website1 %all submit to ! ,secret>y a supplem5tal application = purposes ( *ang+ ! drug's label+ to sub/itute a ref]5ce or hyp]l9k to su* ,website = any susceptibility te/ int]pretive crit]ia & relat$ in=mation2 & 7,b7 may beg9 di/ribution ( ! drug involv$ ^u receipt by ! ,secret>y ( ! supplem5tal application = su* *ange4 7#b7 ,drugs m>ket$ subsequ5t to e/abli%m5t ( ,int]pretive ,crit]ia ,website ,) respect to antimicrobial drugs lawfully introduc$ or deliv]$ = introduction into int]/ate comm]ce = comm]cial di/ribution on or aft] ! date ( ! e/abli%m5t ( ! ,int]pretive ,crit]ia ,website1 ! label+ = su* a drug %all include1 9 lieu ( susceptibility te/ int]pretive crit]ia & relat$ in=mation1 a ref]5ce to su* ,website4 7e7 ,special condition = m>ket+ ( antimicrobial susceptibility te/+ devices 7#a7 ,9 g5]al ,not)/&+ sections #eja1 #ejb1 #eaj1 #eac1 & #eae1 if ! conditions specifi$ 9 p>agraph 7#b7 are met 79 addition to o!r applicable provisions "u ?is *apt]7 ) respect to an antimicrobial susceptibility te/+ device describ$ 9 subsection 7f77#a71 ! ,secret>y may au?orize ! m>ket+ ( su* device = a use describ$ 9 su* subsection4 7#b7 ,conditions applicable to antimicrobial susceptibility te/+ devices ,! conditions specifi$ 9 ?is p>agraph are ! foll[+3 7,a7 ,! device is us$ to make a det]m9ation ( susceptibility us+ susceptibility te/ int]pretive crit]ia t are-- 7i7 includ$ 9 a /&>d recogniz$ by ! ,secret>y "u subsection 7c72 or 7ii7 o!rwise li/$ on ! ,int]pretive ,crit]ia ,website "u subsection 7b77#b74 7,b7 ,! label+ ( su* device prom95tly & conspicu\sly-- 7i7 includes a /atem5t t-- 7,i7 ! device provides in=mation ab\t ! susceptibility ( bact]ia & fungi to c]ta9 drugs2 & 7,,ii7 ! safety & efficacy ( su* drugs 9 treat+ cl9ical infections due to su* bact]ia or fungi may n h be5 e/abli%$ 9 adequate & well-controll$ cl9ical trials & ! cl9ical significance ( su* susceptibility in=mation 9 ^? in/ances is unkn[n2 7ii7 includes a /atem5t direct+ heal? c>e practition]s to consult ! approv$ label+ = drugs te/$ us+ su* a device1 to det]m9e ! uses = :i* ! ,food & ,drug ,adm9i/ration has approv$ su* drugs2 & 7iii7 includes any o!r /atem5t ! ,secret>y det]m9es appropriate to adequately convey ! limitations ( ! data support+ ! int]pretive crit]ia describ$ 9 subp>agraph 7,a74 7f7 ,def9itions ,9 ?is section3 7#a7 ,! t]m antimicrobial susceptibility te/+ device means a device t utilizes susceptibility te/ int]pretive crit]ia to det]m9e & report ! 9 vitro susceptibility ( c]ta9 microorganisms to a drug 7or drugs74 7#b7 ,! t]m qualifi$ infecti\s disease product means a qualifi$ infecti\s disease product designat$ "u section #eje;,e7d74 7#c7 ,! t]m susceptibility te/ int]pretive crit]ia means-- 7,a7 "o or m specific num]ical values :i* *>act]ize ! susceptibility ( bact]ia or o!r microorganisms to ! drug te/$2 & 7,b7 relat$ categorizations ( su* susceptibility1 includ+ categorization ( ! drug z susceptible1 int]m$iate1 resi/ant1 or su* o!r t]m z ! ,secret>y det]m9es appropriate4 7#d7 7,a7 ,! t]m antimicrobial drug means1 subject to subp>agraph 7,b71 a sy/emic antibact]ial or antifungal drug t-- 7i7 is int5d$ = human use 9 ! treatm5t ( a disease or condition caus$ by a bact]ium or fungus2 7ii7 may include a qualifi$ infecti\s disease product designat$ "u section #eje;,e7d72 & 7iii7 is subject to section #ejc7;b77#a74 7,b7 ,if provid$ by ! ,secret>y ?r\gh regulations1 su* t]m may include-- 7i7 drugs o!r ?an sy/emic antibact]ial & antifungal drugs2 & 7ii7 biological products 7z su* t]m is def9$ 9 section #cea ( ! ,public ,heal? ,s]vice ,act7 to ! ext5t su* products exhibit antimicrobial activity4 7g7 ,rule ( con/ruction ,no?+ 9 ?is section %all be con/ru$-- 7#a7 to alt] ! /&>ds ( evid5ce-- 7,a7 "u subsection 7c7 or 7d7 ( section #eje1 includ+ ! sub/antial evid5ce /&>d 9 section #eje7;d71 or "u section #cea ( ! ,public ,heal? ,s]vice ,act 7z applicable72 or 7,b7 ) respect to m>ket+ au?orization = devices1 "u section #eaj1 #eac1 or #eae2 7#b7 to apply ) respect to any drug1 device1 or biological product1 9 any context o!r ?an-- 7,a7 an antimicrobial drug2 or 7,b7 an antimicrobial susceptibility te/+ device t uses susceptibility te/ int]pretive crit]ia to *>act]ize & report ! 9 vitro susceptibility ( c]ta9 bact]ia1 fungi1 or o!r microorganisms to antimicrobial drugs 9 accordance ) ?is section2 or 7#c7 unless specifically /at$1 to h any effect on au?orities provid$ "u o!r sections ( ?is ,act1 includ+ any regulations issu$ "u su* sections4 4 7b7 ,con=m+ am5dm5ts 7#a7 ,repeal ( relat$ au?ority ,section #aaaa ( ! ,food & ,drug ,adm9i/ration ,am5dm5ts ,act ( #bjjg 7#db ,u4,s4,c4 #bdg;d-#e;a2 relat+ to id5tification ( cl9ically susceptible conc5trations ( antimicrobials7 is repeal$4 7#b7 ,misbr&+ ,section #ejb ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb71 z am5d$ by section #a1 is fur!r am5d$ by add+ at ! end ! foll[+3 7ee7 ,if x is an antimicrobial drug & its label+ fails to con=m ) ! requirem5ts "u section #eaa7;d74 4 7#c7 ,recognition ( int]pretive crit]ia z device /&>d ,section #ead7;c77#a77;,a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;d7c77#a77;,a77 is am5d$ by ins]t+ aft] ! ,secret>y %all1 by publication 9 ! ,f$]al ,regi/] ! foll[+3 7or1 ) respect to susceptibility te/ int]pretive crit]ia or /&>ds recogniz$ or o!rwise li/$ "u section #eaa1 by po/+ on ! ,int]pretive ,crit]ia ,website 9 accordance ) su* section74 7c7 ,report to ,congress ,n lat] ?an two ye>s aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices %all submit to ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives & ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate a report on ! progress made 9 implem5t+ section #eaa ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;a71 z am5d$ by ?is section4 7d7 ,reque/s = updates to ,int]pretive ,crit]ia ,website ,*apt] #ce ( title #dd1 ,unit$ ,/ates ,code1 %all n apply to ! collection ( in=mation f int]e/$ p>ties reg>d+ ! updat+ ( li/s "u p>agraph 7#b7 ( subsection 7b7 ( section #eaa ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7z am5d$ by subsection 7a77 & po/$ on ! ,int]pretive ,crit]ia ,website e/abli%$ "u p>agraph 7#a7 ( su* subsection 7b74 7e7 ,no effect on heal? c>e practice ,no?+ 9 ?is ,act 7includ+ ! am5dm5ts made by ?is ,act7 %all be con/ru$ to re/rict1 9 any mann]1 ! prescrib+ or adm9i/]+ ( antibiotics or o!r products by heal? c>e practition]s1 or to limit ! practice ( heal? c>e4